{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,18]],"date-time":"2026-01-18T23:26:08Z","timestamp":1768778768307,"version":"3.49.0"},"reference-count":28,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2002,4,1]],"date-time":"2002-04-01T00:00:00Z","timestamp":1017619200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Leukemia Research"],"published-print":{"date-parts":[[2002,4]]},"DOI":"10.1016\/s0145-2126(01)00147-3","type":"journal-article","created":{"date-parts":[[2002,10,14]],"date-time":"2002-10-14T20:48:11Z","timestamp":1034628491000},"page":"391-398","source":"Crossref","is-referenced-by-count":20,"title":["Arsenic trioxide and methylprednisolone use different signal transduction pathways in leukemic differentiation"],"prefix":"10.1016","volume":"26","author":[{"given":"Safak","family":"Yuksel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guray","family":"Saydam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruchan","family":"Uslu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ulus Ali","family":"Sanli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ender","family":"Terzioglu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Filiz","family":"Buyukececi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Serdar Bedii","family":"Omay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S0145-2126(01)00147-3_BIB1","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1182\/blood.V70.5.1233.1233","article-title":"The HL 60 promyelocytic leukemia cell line: proliferation, and cellular oncogene expression","volume":"70","author":"Collins","year":"1987","journal-title":"Blood"},{"key":"10.1016\/S0145-2126(01)00147-3_BIB2","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1002\/1097-0142(19880915)62:6<1171::AID-CNCR2820620621>3.0.CO;2-8","article-title":"Effect of differentiation-inducing agents on oncogene expression in a chronic myelogenous leukemia cell line","volume":"62","author":"Eisbruch","year":"1988","journal-title":"Cancer"},{"key":"10.1016\/S0145-2126(01)00147-3_BIB3","first-page":"37","article-title":"Arsenoxide in relation to the toxicity and therapeutic activity of arsphenamine and neoarsphenamine","volume":"18","author":"Schamberg","year":"1934","journal-title":"Am. J. Syph. Neurol."},{"key":"10.1016\/S0145-2126(01)00147-3_BIB4","first-page":"305","article-title":"Arsenic as a therapeutic agent in chronic myeloid leukemia","volume":"97","author":"Forkner","year":"1931","journal-title":"JAMA"},{"key":"10.1016\/S0145-2126(01)00147-3_BIB5","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1056\/NEJM199811053391901","article-title":"Complete remission after treatment of acute promyelocytic leukemia with arsenic trioxide","volume":"339","author":"Soignet","year":"1989","journal-title":"NEJM"},{"key":"10.1016\/S0145-2126(01)00147-3_BIB6","first-page":"3345","article-title":"Use of arsenic trioxide (As2O3) in the treatment of acute promyelocytic leukemia (APL): I.As2O3 exerts dose dependent effects on APL cells","volume":"89","author":"Chen","year":"1997","journal-title":"Blood"},{"key":"10.1016\/S0145-2126(01)00147-3_BIB7","doi-asserted-by":"crossref","first-page":"3978","DOI":"10.1073\/pnas.94.8.3978","article-title":"Arsenic-induced PML targeting onto nuclear bodies. Implication for the treatment of acute promyelocytic leukemia","volume":"94","author":"Zhu","year":"1997","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"2","key":"10.1016\/S0145-2126(01)00147-3_BIB8","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1038\/sj.leu.2401650","article-title":"Arsenic trioxide-induced apoptosis and differentiation are associated respectively with mitochondrial transmembrane potential collapse and retinoic acid signalling pathways in acute promyelocytic leukemia","volume":"14","author":"Cai","year":"2000","journal-title":"Leukemia"},{"key":"10.1016\/S0145-2126(01)00147-3_BIB9","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1182\/blood.V92.5.1497","article-title":"Arsenic trioxide and melarsoprol induce programmed cell death in myeloid leukemia cell lines adn function in a PML and PML-RAR\u03b1 independent manner","volume":"92","author":"Wang","year":"1998","journal-title":"Blood"},{"key":"10.1016\/S0145-2126(01)00147-3_BIB10","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1182\/blood.V88.3.1052.1052","article-title":"In vitro studies on cellular and molecular mechanisms of arsenic trioxide (As2O3) in the treatment of acute promyelocytic leukemia. As2O3 induces NB4 cell apoptosis with downregulation of bcl-2 expression and modulation of PML-RAR alpha\/PML proteins","volume":"88","author":"Chen","year":"1996","journal-title":"Blood"},{"key":"10.1016\/S0145-2126(01)00147-3_BIB11","doi-asserted-by":"crossref","first-page":"4300","DOI":"10.1182\/blood.V91.11.4300","article-title":"Combined arsenic and retinoic acid treatment enhances differentiation and apoptosis in arsenic-resistant NB4 cells","volume":"91","author":"Gianni","year":"1998","journal-title":"Blood"},{"key":"10.1016\/S0145-2126(01)00147-3_BIB12","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.3109\/10799899709036612","article-title":"Regulation of gene expression by nuclear hormone receptors","volume":"17","author":"Meier","year":"1997","journal-title":"J. Recept. Signal. Transduct. Res."},{"key":"10.1016\/S0145-2126(01)00147-3_BIB13","doi-asserted-by":"crossref","unstructured":"Hics\u00f6nmez G, Erdemli E, Tekelioglu M, et al. Morphologic evidence of apoptosis in childhood acute myeloblastic leukemia treated with high-dose methylprednisolone. Leuk Lymphoma 1996;22 (1\/2):91\u20136.","DOI":"10.3109\/10428199609051733"},{"key":"10.1016\/S0145-2126(01)00147-3_BIB14","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/0065-2571(94)90017-5","article-title":"Serine\/threonine in the control of cell function","volume":"34","author":"Depaoli-Roach","year":"1994","journal-title":"Adv. Enzyme. Regul."},{"key":"10.1016\/S0145-2126(01)00147-3_BIB15","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1152\/physrev.1993.73.4.673","article-title":"Protein serine\/threonine phosphatases: structure, regulation, and functions in cell growth","volume":"73","author":"Mumby","year":"1993","journal-title":"Physiol. Rev."},{"key":"10.1016\/S0145-2126(01)00147-3_BIB16","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1146\/annurev.bi.58.070189.002321","article-title":"The structure and regulation of protein phosphatases","volume":"58","author":"Cohen","year":"1989","journal-title":"Ann. Rev. Biochem."},{"key":"10.1016\/S0145-2126(01)00147-3_BIB17","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/0014-5793(93)80113-9","article-title":"Down-regulation by retinoic acid of the catalytic subunit of protein phosphatase type 2A during granulocytic differentiation of HL 60 cells","volume":"321","author":"Tawara","year":"1994","journal-title":"FEBS Lett."},{"issue":"4","key":"10.1016\/S0145-2126(01)00147-3_BIB18","first-page":"774","article-title":"Translocation of protein phosphatase 1 catalytic subunits during 1,25-dihydroxyvitamin D3-induced monocytic differentiation of HL 60 cells","volume":"55","author":"Omay","year":"1995","journal-title":"Cancer Res."},{"key":"10.1016\/S0145-2126(01)00147-3_BIB19","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/S0145-2126(99)00040-5","article-title":"Augmentation of methylprednisolone-induced differentiation of myeloid leukemia cells by serine\/threonine phosphatase inhibitors","volume":"23","author":"Uzunoglu","year":"1999","journal-title":"Leuk. Res."},{"issue":"5","key":"10.1016\/S0145-2126(01)00147-3_BIB20","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1046\/j.1365-2257.2000.00326.x","article-title":"Up-regulation of serine\/threonine phosphatase type 2A regulatory subunits during methylprednisolone-induced differentiation of leukemic HL 60 cells","volume":"22","author":"Aydin","year":"2000","journal-title":"Clin. Lab. Haematol."},{"key":"10.1016\/S0145-2126(01)00147-3_BIB21","doi-asserted-by":"crossref","unstructured":"Uemura Y, Nishikawa M, Komada F, et al. Alteration of intracellularactin levels induced by phorbol diester in human HL 60 leukemiacells suspectible or resistant to differentiation, and the effects of protein kinase inhibitors. Leuk Res 1989;13:545.","DOI":"10.1016\/0145-2126(89)90121-5"},{"key":"10.1016\/S0145-2126(01)00147-3_BIB22","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1289\/ehp.94102s3101","article-title":"Differential cytotoxic effects of arsenic on human and animal cells","volume":"102","author":"Lee","year":"1994","journal-title":"Environ. Health. Perspect."},{"key":"10.1016\/S0145-2126(01)00147-3_BIB23","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/S0301-472X(99)00014-4","article-title":"Effect of arsenic trioxide on viability, proliferation and apoptosis in human megakaryocytic leukemia cell lines","volume":"27","author":"Lu","year":"1999","journal-title":"Exp. Hematol."},{"key":"10.1016\/S0145-2126(01)00147-3_BIB24","first-page":"33","article-title":"Arsenic trioxide induces apoptosis of oesophegal carcinoma in vitro","volume":"4","author":"Shen","year":"1999","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/S0145-2126(01)00147-3_BIB25","unstructured":"Uslu R, Sezgin C, Karabulut B, Sanli UA, Tobu M, Saydam G, Byukkececi F,Omay SB, Goker E. Arsenic trioxide-mediated cytotoxicity in prostate and ovarian carcinoma cell lines. In: Proceeding of the 1999 AACR-NCI-EORTC International Conference. pp. 55\u20136 (abstract)."},{"issue":"5","key":"10.1016\/S0145-2126(01)00147-3_BIB26","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1161\/01.RES.86.5.514","article-title":"NADH oxidase activation is involved in arsenite-induced oxidative DNA damage in human vascular smooth muscle cells","volume":"86","author":"Lynn","year":"2000","journal-title":"Circ. Res."},{"issue":"6","key":"10.1016\/S0145-2126(01)00147-3_BIB27","doi-asserted-by":"crossref","first-page":"2102","DOI":"10.1182\/blood.V94.6.2102","article-title":"Arsenic trioxide selectively induces acute promyelocytic leukemia cells apoptosis via a hydrogen peroxide-dependent pathway","volume":"94","author":"Jing","year":"1999","journal-title":"Blood"},{"issue":"4","key":"10.1016\/S0145-2126(01)00147-3_BIB28","first-page":"776","article-title":"Arsenic targets tubulins to induce apoptosis in myeloid leukemia cells","volume":"59","author":"Li","year":"1999","journal-title":"Cancer Res."}],"container-title":["Leukemia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212601001473?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212601001473?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,1,8]],"date-time":"2020-01-08T03:06:30Z","timestamp":1578452790000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0145212601001473"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,4]]},"references-count":28,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2002,4]]}},"alternative-id":["S0145212601001473"],"URL":"https:\/\/doi.org\/10.1016\/s0145-2126(01)00147-3","relation":{},"ISSN":["0145-2126"],"issn-type":[{"value":"0145-2126","type":"print"}],"subject":[],"published":{"date-parts":[[2002,4]]}}}